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a  b  s  t  r  a  c  t
Allergic  reactions  due  to drugs  may  lead  to  different  clinical  conditions.  Acute  coronary  syndromes
triggered  by  Type  1  hypersensitivity  reactions  due  to drug  intake  are  known  as  “Kounis  syndrome.”
Vasospasm  occurring  in  normal  coronary  arteries  (Type  1)  and  plaque  rupture  (Type  2)  are  two  variants
of this  syndrome;  both  caused  by  vasoactive  and  inﬂammatory  mediators  due  to  hypersensitivity  reac-eywords:
llergic reaction
ype 1 hypersensitivity
yocardial infarction
tion. In this  case  report,  we will  present  Type  2 Kounis  syndrome  leading  to acute  anterior  myocardial
infarction  and  cardiac  arrest in  a healthy  male  after  diclofenac  sodium  injection  via intramuscular  route.
<Learning  objective:  Incidence  of Kounis  syndrome  due  to diclofenac  is higher  than  reported.  Some  of
the myocardial  infarction  events  referred  to  in  the  studies  might  be  due  to  Kounis  syndrome.  The risk
of myocardial  infarction  probability  due  to allergic  reactions  after  intake  of these  drugs  must  be  kept  in
3  Jap
on-steroidal anti-inﬂammatory drugs mind  when  prescribing.>
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Allergic reactions due to drug administration may  cause
yocardial infarction (MI) besides chest pain [1]. Diclofenac
odium, which is in wide use as a non-steroidal anti-inﬂammatory
rug (NSAID), may  lead to allergic reactions besides gastrointesti-
al, hepatic, hematologic, and renal adverse effects [2]. Allergic
ngina and MI  may  be triggered by various drugs and is known as
Kounis syndrome” [3]. The exact prevalence of this syndrome has
ot been determined since it is not always reported in the medical
iterature, and it may  lead to life-threatening cardiovascular events
4].
ase report
A 49-year-old male was admitted to a secondary medical cen-
er with complaints of sore throat, generalized pain, and fatigue.
e had diabetes mellitus, hyperlipidemia, and tobacco usage as
ardiovascular risk factors. He did not have any information in
is past medical history except for appendectomy performed 9
ears previously. Slight hyperemia in the pharynx was  observed
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on physical examination. Cardiac examination was  normal. Since
his electrocardiogram (ECG) was  normal at that time, acute coro-
nary syndrome (ACS) was  excluded (Fig. 1). Diclofenac sodium
via intramuscular route was administered to the patient. Cardiac
arrest due to ventricular ﬁbrillation occurred ﬁve minutes after
diclofenac injection. After successful deﬁbrillation and cardiopul-
monary resuscitation, an emergent ECG was taken which was
compatible with acute anterior MI  (Fig. 2). The patient was trans-
ferred to our department.
He was  unconscious and had pulmonary edema. His blood
pressure was  80/40 mmHg  He had been emergently taken to
the catheter laboratory. His left anterior descending (LAD) was
occluded just distal to the ﬁrst diagonal branch (Fig. 3a). Intra-
coronary nitroglycerin (0.25 mg)  was  administered, which showed
no beneﬁt. After placement of a ﬂoppy guidewire in the LAD,
grade 2–3 thrombolysis in myocardial infarction ﬂow was  achieved.
Successful primary percutaneous coronary intervention (PCI) was
performed (Fig. 3b) by direct stenting of the vessel. He was trans-
ferred to the coronary care unit. Fourth hour control ECG showed
resolution of ST segment elevation (Fig. 4) and the patient started
to gain consciousness at 6 h from onset.There was  neutrophilia in his complete blood count. Bio-
chemical tests showed hyperglycemia (359 mg/dl), hyperlipidemia
(low-density lipoprotein cholesterol, 248 mg/dl), marked elevation
of cardiac enzymes, and a slight elevation of creatinine (1.6 mg/dl).
vier Ltd. All rights reserved.
e18 C.E. Cagliyan et al. / Journal of Cardiology Cases 8 (2013) e17–e19
Fig. 1. Normal electrocardiogram before diclofenac injection.
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is serum IgE levels were found to be 1300 IU/mL (normal range:
–165 IU/dl). The patient was diagnosed as having Kounis Syn-
rome leading to acute anterior MI.  Since he was stable during his
ollow-up, he was discharged on day 5.
iscussion
Administration of NSAIDs has been blamed for develop-
ent of ACS in recent decades. Since they alter the balance
etween thromboxane-prostacyclin equilibrium, they may  lead
o vasospasm and development of small platelet thrombi [5].
iclofenac has been found to be associated with ACS in somepatible with acute anterior myocardial infarction.
studies [6,7]. However, NSAIDs are usually associated with
increased risk of non-ST elevation ACS instead of ST elevation MI
[5].
Type 1 hypersensitivity reaction occurring by vasoactive amines
such as histamine and serotonin plays a role in the pathophysiology
of MI  cases developing after drug administration [3]. Two types of
Kounis syndrome have been described by Kounis and colleagues.
Type 1 develops in normal coronary arteries and vasospasm due to
endothelial dysfunction is the main mechanism. However, Type 2
variant occurs in the coronary atherosclerotic plaques and rupture
triggered by allergic reaction leading to MI  is the main mechanism.
Although many drugs are thought to be associated with Kounis
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Fig. 3. (a) Coronary angiography showing complete occlusion of the mid  segment of the LAD (white arrow). (b) Coronary ﬂow is maintained after successful stent implantation.
LAD,  left anterior descending; CX, circumﬂex.
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yndrome, anti-inﬂammatory, antihistaminic, and antibiotic drugs
re the most frequently responsible agents; especially when
dministered to atopic individuals [3].
In the studies investigating the adverse effects of NSAIDs, the
ardiovascular ones such as ACS and MI  are attributed to the
nti-prostacyclin effects of these drugs [6–8]. There are only two
eported cases of MI  due to Kounis syndrome triggered by the
iclofenac molecule [9,10]. Abrupt onset after intake of the drug
nd high IgE levels are typical supportive clinical features. We  think
hat the incidence of Kounis syndrome due to diclofenac is higher
han reported. Some of the MI  events referred to in the studies
ight be due to Kounis syndrome. The risk of MI  probability due to
llergic reactions after intake of these drugs must be kept in mind
hen prescribing.
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